Loss of high-molecular-weight cytokeratin antigenicity in prostate tissue obtained by transurethral resections.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Loss of high-molecular-weight cytokeratin antigenicity in prostate tissue obtained by transurethral resections. / Multhaupt, H A; Fessler, J N; Warhol, M J.

In: Archives of Pathology & Laboratory Medicine, Vol. 124, No. 12, 2000, p. 1764-7.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Multhaupt, HA, Fessler, JN & Warhol, MJ 2000, 'Loss of high-molecular-weight cytokeratin antigenicity in prostate tissue obtained by transurethral resections.', Archives of Pathology & Laboratory Medicine, vol. 124, no. 12, pp. 1764-7.

APA

Multhaupt, H. A., Fessler, J. N., & Warhol, M. J. (2000). Loss of high-molecular-weight cytokeratin antigenicity in prostate tissue obtained by transurethral resections. Archives of Pathology & Laboratory Medicine, 124(12), 1764-7.

Vancouver

Multhaupt HA, Fessler JN, Warhol MJ. Loss of high-molecular-weight cytokeratin antigenicity in prostate tissue obtained by transurethral resections. Archives of Pathology & Laboratory Medicine. 2000;124(12):1764-7.

Author

Multhaupt, H A ; Fessler, J N ; Warhol, M J. / Loss of high-molecular-weight cytokeratin antigenicity in prostate tissue obtained by transurethral resections. In: Archives of Pathology & Laboratory Medicine. 2000 ; Vol. 124, No. 12. pp. 1764-7.

Bibtex

@article{cd326e205d3f11dd8d9f000ea68e967b,
title = "Loss of high-molecular-weight cytokeratin antigenicity in prostate tissue obtained by transurethral resections.",
abstract = "OBJECTIVE: Staining of prostatic basal cells for the expression of high-molecular-weight cytokeratin has been suggested as a way of distinguishing benign from malignant prostate glands. We evaluated the utility of high-molecular-weight cytokeratin in the diagnosis of malignancy in prostate specimens obtained in various ways. DESIGN: Prostate tissues obtained from needle biopsies, transurethral resections, and total prostatectomies were immunostained with monoclonal antibody 34betaE12, an antibody directed against high-molecular-weight cytokeratins. RESULTS: Antiserum to high-molecular-weight cytokeratin only stained the basal cells in normal glands in 3 (12%) of 25 specimens obtained by transurethral resection. Other antigens, such as the alternate 10-nm filament protein vimentin, were unaffected and were detected in 100% of these specimens. However, keratin antigenicity in transurethral biopsies could be restored in these specimens by antigen retrieval in a low pH citrate buffer using a microwave heat technique. Keratin staining in needle biopsies and total prostatectomies was unaffected. CONCLUSION: In summary, our results indicate the technique of transurethral resection results in a specific loss of keratin antigenicity. This limits the utility of anticytokeratin 34betaE12 in interpreting transurethral resections without the application of antigen retrieval.",
author = "Multhaupt, {H A} and Fessler, {J N} and Warhol, {M J}",
note = "Keywords: Adenocarcinoma; Antibodies, Monoclonal; Biopsy, Needle; Diagnosis, Differential; Humans; Immunohistochemistry; Keratins; Male; Molecular Weight; Prostate; Prostatectomy; Prostatic Neoplasms; Transurethral Resection of Prostate",
year = "2000",
language = "English",
volume = "124",
pages = "1764--7",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "12",

}

RIS

TY - JOUR

T1 - Loss of high-molecular-weight cytokeratin antigenicity in prostate tissue obtained by transurethral resections.

AU - Multhaupt, H A

AU - Fessler, J N

AU - Warhol, M J

N1 - Keywords: Adenocarcinoma; Antibodies, Monoclonal; Biopsy, Needle; Diagnosis, Differential; Humans; Immunohistochemistry; Keratins; Male; Molecular Weight; Prostate; Prostatectomy; Prostatic Neoplasms; Transurethral Resection of Prostate

PY - 2000

Y1 - 2000

N2 - OBJECTIVE: Staining of prostatic basal cells for the expression of high-molecular-weight cytokeratin has been suggested as a way of distinguishing benign from malignant prostate glands. We evaluated the utility of high-molecular-weight cytokeratin in the diagnosis of malignancy in prostate specimens obtained in various ways. DESIGN: Prostate tissues obtained from needle biopsies, transurethral resections, and total prostatectomies were immunostained with monoclonal antibody 34betaE12, an antibody directed against high-molecular-weight cytokeratins. RESULTS: Antiserum to high-molecular-weight cytokeratin only stained the basal cells in normal glands in 3 (12%) of 25 specimens obtained by transurethral resection. Other antigens, such as the alternate 10-nm filament protein vimentin, were unaffected and were detected in 100% of these specimens. However, keratin antigenicity in transurethral biopsies could be restored in these specimens by antigen retrieval in a low pH citrate buffer using a microwave heat technique. Keratin staining in needle biopsies and total prostatectomies was unaffected. CONCLUSION: In summary, our results indicate the technique of transurethral resection results in a specific loss of keratin antigenicity. This limits the utility of anticytokeratin 34betaE12 in interpreting transurethral resections without the application of antigen retrieval.

AB - OBJECTIVE: Staining of prostatic basal cells for the expression of high-molecular-weight cytokeratin has been suggested as a way of distinguishing benign from malignant prostate glands. We evaluated the utility of high-molecular-weight cytokeratin in the diagnosis of malignancy in prostate specimens obtained in various ways. DESIGN: Prostate tissues obtained from needle biopsies, transurethral resections, and total prostatectomies were immunostained with monoclonal antibody 34betaE12, an antibody directed against high-molecular-weight cytokeratins. RESULTS: Antiserum to high-molecular-weight cytokeratin only stained the basal cells in normal glands in 3 (12%) of 25 specimens obtained by transurethral resection. Other antigens, such as the alternate 10-nm filament protein vimentin, were unaffected and were detected in 100% of these specimens. However, keratin antigenicity in transurethral biopsies could be restored in these specimens by antigen retrieval in a low pH citrate buffer using a microwave heat technique. Keratin staining in needle biopsies and total prostatectomies was unaffected. CONCLUSION: In summary, our results indicate the technique of transurethral resection results in a specific loss of keratin antigenicity. This limits the utility of anticytokeratin 34betaE12 in interpreting transurethral resections without the application of antigen retrieval.

M3 - Journal article

C2 - 11100054

VL - 124

SP - 1764

EP - 1767

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 12

ER -

ID: 5240250